Aspire Biopharma Holdings Inc
ASBP
Aspire Biopharma Holdings Inc AI Insights
Informational only. Not investment advice.Snapshot
- Negative equity of -11.5M with 8.6M total debt - technically insolvent with liabilities 5.8x assets (13.9M vs 2.4M TTM)[Common Stockholders Equity]
- Revenue TTM of just $1,941 against 20M operating expenses - burn rate exceeds revenue by 10,000x[Total Revenue TTM]
- Cash of 1.9M vs current liabilities of 13.9M - working capital deficit of -11.5M signals near-term liquidity crisis[Working Capital]
Watch Triggers
- Cash and Equivalents: Falls below 1M or new financing announced — At -3.5M annual burn, sub-1M cash triggers immediate survival risk
- Total Revenue TTM: Exceeds 500K quarterly — Any material revenue signals commercial viability and potential path to survival
- Shares Outstanding: Increases >20% from 49.5M — Dilutive financing likely imminent - watch for equity raises
Bull Case
Gross margin of 45.5% on minimal revenue suggests product viability if scale achieved; R&D spend of 208K indicates active development
Market cap of 4.2M with 1.9M cash - trading near cash value if restructuring succeeds
Bear Case
Negative equity (-11.5M) and current liabilities (13.9M) exceeding total assets (2.4M) by 5.8x - balance sheet is broken
P/S ratio of 2,176x reflects near-zero revenue ($1,941 TTM) - no commercial traction despite operating expenses of 20M
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage ASBP's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Company faces imminent dilution or restructuring - cash runway under 6 months at current burn
- 3.5M FCF burn TTM with only 1.9M cash
- 8.6M debt coming due (all current)
- No revenue to service obligations
Public Strategies Rankings
See how Aspire Biopharma Holdings Inc ranks across different investment strategies.
Leverage ASBP's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
ASBP Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$5.17M | — | ||
$11.84M | — | ||
0.00 | — | ||
$1,941 | — | ||
$-0.64 | — | ||
-1,032,838% | -1032838.2% | — | |
-1,636,601% | -1636600.9% | — | |
$-3.52M | — | ||
0.00 | — | ||
Beta 5Y (Monthly) | unknown | — |
ASBP Dividend History
ASBP Stock Splits
ASBP SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/14/25 | 09/30/25 | 10-Q | |
08/13/25 | 06/30/25 | 10-Q | |
05/14/25 | 03/31/25 | 10-Q | |
04/07/25 | 12/31/24 | 10-K | |
01/14/25 | 09/30/24 | 424B3 | |
09/06/24 | 06/30/24 | S-4 | |
08/13/25 | 03/31/24 | 10-Q/A | |
05/14/25 | 03/31/24 | 10-Q | |
01/14/25 | 12/31/23 | 424B3 | |
01/14/25 | 09/30/23 | 424B3 | |
09/06/24 | 06/30/23 | S-4 |